Efficacy and Safety of Adalimumab Plus Medium Dose Oral Glucocorticosteroid for Refractory Behçet's Uveitis

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Efficacy and Safety of Adalimumab Plus Medium Dose Oral Glucocorticosteroid for Refractory Behçet's Uveitis	eye disorder, uveal disorder, uveitis	Not yet recruiting	Phase 4	2021-11-03		NCT05105347

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Peking Union Medical College Hospital	417

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials